Detalhe da pesquisa
1.
Graft-versus-mastocytosis effect after donor lymphocyte infusion: Proof of principle.
Eur J Haematol
; 106(2): 290-293, 2021 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-33010068
2.
Tyrosine kinase inhibitor usage, treatment outcome, and prognostic scores in CML: report from the population-based Swedish CML registry.
Blood
; 122(7): 1284-92, 2013 Aug 15.
Artigo
Inglês
| MEDLINE | ID: mdl-23843494
3.
Combination of pegylated IFN-α2b with imatinib increases molecular response rates in patients with low- or intermediate-risk chronic myeloid leukemia.
Blood
; 118(12): 3228-35, 2011 Sep 22.
Artigo
Inglês
| MEDLINE | ID: mdl-21685374
4.
Mobilized peripheral blood stem cells compared with bone marrow from HLA-identical siblings for reduced-intensity conditioning transplantation in acute myeloid leukemia in complete remission: a retrospective analysis from the Acute Leukemia Working Party of EBMT.
Eur J Haematol
; 89(3): 206-13, 2012 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-22650267
5.
Successful mobilization of Ph-negative blood stem cells with intensive chemotherapy + G-CSF in patients with chronic myelogenous leukemia in first chronic phase.
Leuk Lymphoma
; 47(9): 1768-73, 2006 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-17064986
6.
Myeloablative allogeneic stem cell transplantation for lymphoblastic lymphoma in Sweden: a retrospective study.
Am J Hematol
; 86(8): 709-10, 2011 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-21761436
7.
Comparison of busulphan, hydroxyurea and allogeneic bone marrow transplantation (BMT) in chronic myeloid leukaemia: BMT prolongs survival.
Hematol J
; 5(6): 462-6, 2004.
Artigo
Inglês
| MEDLINE | ID: mdl-15570285
8.
Adjusted conditioning for allogeneic transplantation in a single center setting: mixed chimerism heralds relapse.
Leuk Lymphoma
; 44(4): 669-79, 2003 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-12769345
9.
Allogeneic hematopoietic stem cell transplant with reduced-intensity conditioning for chronic lymphocytic leukemia in Sweden: does donor T-cell engraftment 3 months after transplant predict survival?
Leuk Lymphoma
; 53(9): 1699-705, 2012 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-22335529
10.
Treatment-related risk factors for transformation to acute myeloid leukemia and myelodysplastic syndromes in myeloproliferative neoplasms.
J Clin Oncol
; 29(17): 2410-5, 2011 Jun 10.
Artigo
Inglês
| MEDLINE | ID: mdl-21537037
11.
More potent graft-versus-myeloma effect than graft-versus-renal cell cancer effect.
Leuk Lymphoma
; 43(11): 2233-4, 2002 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-12533054
12.
Long-term survival after allogeneic stem cell transplant for relapsed large B cell lymphomas: a retrospective study.
Leuk Lymphoma
; 53(3): 503-5, 2012 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-21864035
13.
Different outcome of allogeneic transplantation in myelofibrosis using conventional or reduced-intensity conditioning regimens.
Br J Haematol
; 135(3): 367-73, 2006 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-16972981
14.
Long-term survival following allogeneic or syngeneic stem cell transplant for follicular lymphoma in Sweden.
Leuk Lymphoma
; 52(1): 69-71, 2011 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-20919855
15.
Intensive treatment and stem cell transplantation in chronic myelogenous leukemia: long-term follow-up.
Acta Haematol
; 113(3): 155-62, 2005.
Artigo
Inglês
| MEDLINE | ID: mdl-15870485
16.
Intensive chemotherapy in patients with chronic myelogenous leukaemia (CML) in accelerated or blastic phase--a report from the Swedish CML Group.
Br J Haematol
; 118(4): 1048-54, 2002 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-12199784
17.
High-dose cytarabine in upfront therapy for adult patients with acute lymphoblastic leukaemia.
Br J Haematol
; 118(3): 748-54, 2002 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-12181041